BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asnani A. Activating Autophagy to Prevent Doxorubicin Cardiomyopathy: The Timing Matters. Circ Res 2021;129:801-3. [PMID: 34591656 DOI: 10.1161/CIRCRESAHA.121.320063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Peng Y, Wang L, Zhang Z, He X, Fan Q, Cheng X, Qiao Y, Huang H, Lai S, Wan Q, He M, He H. Puerarin activates adaptive autophagy and protects the myocardium against doxorubicin-induced cardiotoxicity via the 14–3-3γ/PKCε pathway. Biomedicine & Pharmacotherapy 2022;153:113403. [DOI: 10.1016/j.biopha.2022.113403] [Reference Citation Analysis]
2 Li W, Qu X, Kang X, Zhang H, Zhang X, Hu H, Yao L, Zhang L, Zheng J, Zheng Y, Zhang J, Xu Y. Silibinin eliminates mitochondrial ROS and restores autophagy through IL6ST/JAK2/STAT3 signaling pathway to protect cardiomyocytes from doxorubicin-induced injury. Eur J Pharmacol 2022;929:175153. [PMID: 35839932 DOI: 10.1016/j.ejphar.2022.175153] [Reference Citation Analysis]
3 L'Abbate S, Chianca M, Fabiani I, Del Franco A, Giannoni A, Vergaro G, Grigoratos C, Kusmic C, Passino C, D'Alessandra Y, Burchielli S, Emdin M, Cardinale DM. In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation. J Cardiovasc Transl Res 2022. [PMID: 35312959 DOI: 10.1007/s12265-022-10231-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li X, Wang X, Wang B, Chi W, Li Z, Zhang M, Shen Y, Liu X, Lu Y, Liu Y. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]